Glycated albumin and risk of death and hospitalizations in diabetic dialysis patients.

@article{Freedman2011GlycatedAA,
  title={Glycated albumin and risk of death and hospitalizations in diabetic dialysis patients.},
  author={Barry I. Freedman and Lilian Andries and Zakariya K. Shihabi and Michael V. Rocco and J. Robert Byers and Cesar Y Cardona and Michael A. Pickard and David L. Henderson and Margie V Sadler and Leah M Courchene and Jean R Jordan and Somer S Balderston and Angie D Graham and Vicki L Mauck and Gregory B. Russell and Anthony J. Bleyer},
  journal={Clinical journal of the American Society of Nephrology : CJASN},
  year={2011},
  volume={6 7},
  pages={1635-43}
}
BACKGROUND AND OBJECTIVES Relative to hemoglobin (Hb) A(₁c), glycated albumin (GA) more accurately reflects glycemic control in patients with diabetes mellitus and ESRD. We determined the association between GA, HbA(₁c), and glucose levels with survival and hospitalizations in diabetic dialysis patients. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS Quarterly GA levels were measured for up to 2.33 years in 444 prevalent patients with diabetes and ESRD. Proportional hazard time-dependent… CONTINUE READING
38 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 38 extracted citations

Similar Papers

Loading similar papers…